Adrenal Myelolipoma

Article Author:
Maria Bokhari
Hassam Zulfiqar

Article Editor:
Vishnu Garla

Editors In Chief:
Stephen Leslie
Karim Hamawy

Managing Editors:
Avais Raja
Orawan Chaigasame
Carrie Smith
Abdul Waheed
Khalid Alsayouri
Trevor Nezwek
Radia Jamil
Patrick Le
Anoosh Zafar Gondal
Saad Nazir
William Gossman
Hassam Zulfiqar
Steve Bhimji
John Shell
Matthew Varacallo
Heba Mahdy
Ahmad Malik
Sarosh Vaqar
Mark Pellegrini
James Hughes
Beata Beatty
Nazia Sadiq
Hajira Basit
Phillip Hynes
Tehmina Warsi

6/16/2019 11:01:10 PM


Adrenal myelolipoma is a  benign adrenal neoplasm predominantly composed of mature adipose tissue and intermixed myeloid tissue.They comprise 6-16% of adrenal incidentaloms and are the second most common cause after adrenal adenomas. The increased prevalence of adrenal myelolipomas is due to increased detection because of wider accessibility of computed tomography (CT) and magnetic resonance imaging (MRI) scans. Rarely, myelolipomas are encountered outside the adrenal glands and are termed as extra adrenal myelolipomoas. The pathogenesis of adrenomyalolipomas is either believed to be due to metaplastic change in the mesenchymal cells or as a result of overstimualtion by adrenocorticotrophic hormone (ACTH). Clinically, they may be asymptomatic or present with abdominal pain, nausea or vomiting. On CT scan they appear as well circumscribed, hypodense masses with an attenuation of -90 to -120 HU. Surgical resection is indicated in cases of significant growth or hormonal hypersecretion. [1][2][3][4]


The etiopathogenesis of adrenal myelolipomas is not definitively known. One hypothesis suggests that stimuli, such as necrosis or inflammation could lead to the metaplasia of the reticuloendothelial cells which could lead to the development of adrenal myelolipomas. This hypothesis is supported by the increased incidence of the lesion in the advanced years of life. Another hypothesis claiims that adipocytes develop from the mesechymal stem cells in the endothelium, this results in inflammation leading the adrenal cortex to secrete mediators responsibel for the recruitment of hematopoietic progenitors. Lastly, Hans et al noted in their experiments that injection of anterior pituitary extract in rats lead to the transofrmation of adrenal cortex into bone marrow like tissue. Therefore, it was hypothesized that excess ACTH could be responsible foe the pathogenesis of adrenal  myelolipomas. This theory is supported by the increased incidence of adrenal myelolipomas in congenital adrenal hyperplasia (CAH) where the levels of ACTH can be very high. Adrenal myelolipoma is often associated with conditions like Cushing disease, obesity, hyperlipidemia, hypertension, and diabetes which can be considered as adrenal stimulants. Other theories propose that stressful lifestyle and an unbalanced diet may also play a role in the natural history of the neoplasm.[4][5][5]


Adrenal myelolipomas are the second most common adrenal incidentalomas comprising of 6-16% of adrenal incidentalomas. They have an approximate autopsy prevalence of 0.08% to 0.2%. They are usually recognized in adulthood with a medican age of diagnosis around 51 years. There is no gender predilection. There may be a slight right sided predilection as reported by some studies.[6]


The size of adrenal myelolipomas is variable and can range from as few millimeters to greater than 10 cm when they are termed as giant adrenomyelolipomas. The largest adrenal myelolipoma reported to date weighed 6 kg. Extra-adrenal sites for myelolipomas include the retroperitoneum, thorax, and pelvis. Usually unilateral however they can also involve both adrenals. 


On gross pathologic examination, a cut section of a myelolipoma has a variegated appearance consisting of bright yellow areas of fat, dark red areas of hematopoietic myeloid tissue, and areas with intermixed red and yellow components. On histopathologic examination, myelolipomas are predominantly composed of fatty areas with interspersed hematopoietic tissue components. These fatty elements and hematopoietic areas may be clearly separated, or they are often intermixed. Tissue analysis often reveals a variable amalgamation of myeloid and erythroid cells, megakaryocytes, and occasionally lymphocytes. In an isolated adrenal myelolipoma, a peripheral rim of normal adrenal cortical tissue can be commonly identified distinctly from the mass. Rarely the myelolipomas can contain osteoid tissue in addition to the myeloid tissue. The hemorrhagic areas may be partly replaced by fibrotic tissue or may undergo calcification.[7]

History and Physical

The most common presenting symptoms for adrenal myelolipomas are as follows:

1. Abdominal pain--22.5%

2. Hypochondrial pain--13.9%

3. Flank pain--13.9%

4. Abdominal mass--5.2%

Rarely, dyspnea, back pain, fever, weight loss, and virilization can be the presenting symptoms of adrenal myelolipomas. 

Four recognizable clinicopathologic patterns of adrenal myelolipomas are as follows: 

Isolated Adrenal Myelolipoma: Myelolipomas occurring in an otherwise normal adrenal gland are the most common pattern of presentation. They are asymptomatic and are incidentally identified during the imaging investigation performed for some other reason.

Adrenal Myelolipoma with Acute Hemorrhage: Retroperitoneal hemorrhage is the most common complication occurring in adrenal myelolipoma. Isolated larger lesions (typically over 4 cm in size) and those predominantly composed of fat (greater than 50%) have a greater propensity for a hemorrhagic event.  

Extra-adrenal Myelolipoma: Myelolipomas occurring outside the adrenal gland is most commonly found in the retroperitoneum where presacral or perirenal location are reported as the most common. Patients usually have no endocrine disorder or acute hemorrhage.

Adrenal Myelolipoma with Associated Adrenal Disease: Less commonly patients with adrenal myelolipoma tend to have an endocrine disorder: hypercortisolism (Cushing syndrome), congenital adrenal hyperplasia and primary hyperaldosteronism have been reported in patients with symptomatic adrenal myelolipomas.


Ultrasonography (USG), CT, and MRI  all are highly beneficial in the diagnosis of adrenal myelolipoma, with CT scan being the most sensitive for identification of fat within the lesions. As these tumors are nonfunctional, endocrinological tests are not useful as these lesions are mostly functionally inert. The differential diagnosis of fat containing retroperitoneal masses would include retroperitoneal lipoma or liposarcoma and renal angiomyolipoma.

USG: Myelolipoma has the typical appearance of a hyperechoic mass with intermixed hypoechoic regions. Echogenicity is mainly determined by the variable proportions of the constituent elements in the lesion. The areas of intermixed fatty and myeloid tissue are the most echogenic, whereas regions of pure fat may appear hypoechoic. Because of inhomogeneous architecture, myelolipomas often have heterogeneous echogenicity. Calcification foci appear hyperechoic with acoustic shadowing. Myelolipoma has vague and no appreciable margins due having almost the same echogenicity as surrounding retroperitoneal fat. Hemorrhage alters the sonographic picture, with hemorrhagic areas appearing hypoechoic compared with fat.[8][9]

CT: CT is the preferred imaging modality for the diagnosis of adrenal myelolipoma. It is seen as a hypodense well circumscribed heterogenous mass with an attenuation value of -90 to -129 HU. Almost all myelolipomas have some focus of fat, although the fatty tissue focus may be very small. Large amounts of fat are frequently encountered with “smoky” or "variegated" areas of interspersed higher-attenuation tissue. This denser tissue has attenuation values of 20 HU to 30 HU, inferring the presence of both fat and myeloid elements. Myelolipomas are usually relatively well circumscribed, however, due to the presence of abundant fat they can be difficult to distinguish from surrounding retroperitoneal fat. Foci of punctate calcification may be seen in 25% to 30% of cases. CT is the most sensitive for detecting hemorrhage which may be hyper to hypodense depending on the age of evolution.

MRI: The predominantly fatty areas in myelolipoma appear hyperintense on T1 MR images and intermediate to hyperintense on T2. Admixed marrowlike elements have medium intensity signals similar to that of the spleen. Fat-suppression techniques are best for demonstrating the fat in a myelolipoma with MR imaging. The presence of marrow like elements or hemorrhage results in persistent areas of increased signal intensity on fat-suppressed MR images. Opposed-phase imaging demonstrates signal loss in admixed voxels containing both fat and myeloid tissue which is also described for adrenal adenoma and other masses with mixed components. At MR imaging, the signal intensity will vary depending on the presence and age of hemorrhage. Post-contrast images show a striking enhancement. The imaging features of extra-adrenal myelolipoma are similar to those of adrenal myelolipoma and do not allow distinction extra-adrenal myelolipoma from other fat-containing tumors.

Positron emission tomography (PET): Adrenal myelolipomas typically do not demonstrate an avid FDG uptake, which is usually less than that of the liver. However, in rare instances, the adenomatous and hematopoietic elements can show an increased FDG uptake.

Treatment / Management

Management of adrenal myelolipoma should be decided upon the size of lesion and presence of symptoms. Small lesions measuring less than 5 cm, and those who are asymptomatic are usually monitored via imaging over a period of one to two years. According to various studies, it is suggested that symptomatic tumors or myelolipomas larger than 7 cm should undergo elective surgical excision. The approach is based on the reported incidence of life-threatening emergencies caused by spontaneous rupture and hemorrhage within large lesions. Conventional or endoscopic access may be chosen according to the size of the tumor. Mini-invasive and endoscopic techniques are best utilized for smaller-sized lesions, depending on the expertise of the operator. Conventional methods including transabdominal, lumbar, subcostal or posterior access laparotomy operations have all been described in the literature. An extraperitoneal approach is preferable as it leads to quicker recovery of the patient and lesser postoperative complications. The midline approach is indicated for masses larger than 10 cm or in cases where there are adhesions and infiltration of the surrounding structures. Follow up is mandatory regardless of which surgical method has been employed. There is no evidence of malignant transformation in the literature.[10][11][12]

Differential Diagnosis

 1. Benign adrenal adenoma: These are the commonest adrenal incidentalomas. They are well circumscribed, homogenous masses which have an attenuation value of less than 10 HU in most cases. This low attenuation is due to the fatty tissue present in the adenoma. Occasionally, lipid-poor adenomas are observed which have an attenuation value of greater than 10 HU.

2. Adrenal carcinoma: These are big lobulated tumors with a heterogeneous appearance due to hemorrhage and necrosis. They have irregular margins and invade the surrounding structures, inferior vena cava, kidney, and liver. They have an attenuation value of greater than 10 HU and show increased uptake on the PET scan as well.

3. Retroperitoneal liposarcoma: This is a slow-growing tumor of the retroperitoneal region which is composed of adipocytes and radiologically appears similar to an adrenal myelolipoma.

4. Renal angiomyolipoma: Angiomyolipomas are tumors which comprise of fat, blood vessels, and muscle cells. These are large, heterogeneous appearing tumors which can invade through the renal capsule. The radiological appearance is similar to that of an adrenal myelolipoma with negative attenuation values; however, this is seen to arise from the kidney.

Enhancing Healthcare Team Outcomes

Healthcare workers like the primary caregiver and nurse practitioner should be familiar with myelolipomas and their presentation. Depending on the location, the appropriate specialist should be consulted. Adrenal myelolipoma is a rare benign neoplasm predominantly composed of mature adipose tissue and intermixed myeloid tissue. Myelolipomas are most often encountered in the adrenal gland but may rarely occur in other sites. The majority of small lesions can be monitored as long as one is absolutely sure, there is no occult malignancy. Larger lesions may need excision.

  • Image 5612 Not availableImage 5612 Not available
    Contributed by Jinnah Hospital; Lahore, Pakistan
Attributed To: Contributed by Jinnah Hospital; Lahore, Pakistan

Interested in Participating?

We are looking for contributors to author, edit, and peer review our vast library of review articles and multiple choice questions. In as little as 2-3 hours you can make a significant contribution to your specialty. In return for a small amount of your time, you will receive free access to all content and you will be published as an author or editor in eBooks, apps, online CME/CE activities, and an online Learning Management System for students, teachers, and program directors that allows access to review materials in over 500 specialties.

Improve Content - Become an Author or Editor

This is an academic project designed to provide inexpensive peer-reviewed Apps, eBooks, and very soon an online CME/CE system to help students identify weaknesses and improve knowledge. We would like you to consider being an author or editor. Please click here to learn more. Thank you for you for your interest, the StatPearls Publishing Editorial Team.

Adrenal Myelolipoma - Questions

Take a quiz of the questions on this article.

Take Quiz
Choose the false statement about adrenal myelolipomas.

Click Your Answer Below

Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.

Sign Up
Which is true regarding adrenal myelolipomas?

Click Your Answer Below

Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.

Sign Up

Adrenal Myelolipoma - References


Wang F,Liu J,Zhang R,Bai Y,Li C,Li B,Liu H,Zhang T, CT and MRI of adrenal gland pathologies. Quantitative imaging in medicine and surgery. 2018 Sep     [PubMed]
Haro A,Fujishita T,Nishikawa H,Taguchi Y,Kouda T,Kajiwara K,Makino H,Kanematsu T,Oshiro Y,Yokoyama H, A rare case of gradual enlargement of a multifocal myelolipoma of the posterior mediastinum for 12 years after surgical resection of an adrenal myelolipoma. International journal of surgery case reports. 2018     [PubMed]
Wadood DQ,Qureshi DSA,Singh DP,Freedman DJ, A rare case of co-existing adrenal and pelvic myelolipomas. Radiology case reports. 2018 Oct     [PubMed]
Decmann Á,Perge P,Tóth M,Igaz P, Adrenal myelolipoma: a comprehensive review. Endocrine. 2018 Jan     [PubMed]
Liu W,Chen W,He X, An Unusual Cause of Cushing's Syndrome and Virilization. Gastroenterology. 2015 Oct     [PubMed]
Lam AK, Lipomatous tumours in adrenal gland: WHO updates and clinical implications. Endocrine-related cancer. 2017 Mar     [PubMed]
Littrell LA,Carter JM,Broski SM,Wenger DE, Extra-adrenal myelolipoma and extramedullary hematopoiesis: Imaging features of two similar benign fat-containing presacral masses that may mimic liposarcoma. European journal of radiology. 2017 Aug     [PubMed]
Wilson B,Becker A,Estes T,Keshavamurthy J,Pucar D, Adrenal Hemangioma Definite Diagnosis on CT, MRI, and FDG PET in a Patient With Primary Lung Cancer. Clinical nuclear medicine. 2018 Jun     [PubMed]
Campbell MJ,Obasi M,Wu B,Corwin MT,Fananapazir G, The radiographically diagnosed adrenal myelolipoma: what do we really know? Endocrine. 2017 Nov     [PubMed]
Shenoy VG,Thota A,Shankar R,Desai MG, Adrenal myelolipoma: Controversies in its management. Indian journal of urology : IJU : journal of the Urological Society of India. 2015 Apr-Jun     [PubMed]
Olivier CM,Carballido JA, [Myelolipoma of the adrenal gland: preoperative diagnostic approach]. Actas urologicas espanolas. 1989 May-Jun     [PubMed]
Baisakh MR,Chattoraj A,Narayanan R,Mohanty R,Mishra M, Adrenal myelolipoma: A rare lesion of adrenal gland. Indian journal of cancer. 2015 Oct-Dec     [PubMed]


The intent of StatPearls is to provide practice questions and explanations to assist you in identifying and resolving knowledge deficits. These questions and explanations are not intended to be a source of the knowledge base of all of medicine, nor is it intended to be a board or certification review of Surgery-Urologic. The authors or editors do not warrant the information is complete or accurate. The reader is encouraged to verify each answer and explanation in several references. All drug indications and dosages should be verified before administration.

StatPearls offers the most comprehensive database of free multiple-choice questions with explanations and short review chapters ever developed. This system helps physicians, medical students, dentists, nurses, pharmacists, and allied health professionals identify education deficits and learn new concepts. StatPearls is not a board or certification review system for Surgery-Urologic, it is a learning system that you can use to help improve your knowledge base of medicine for life-long learning. StatPearls will help you identify your weaknesses so that when you are ready to study for a board or certification exam in Surgery-Urologic, you will already be prepared.

Our content is updated continuously through a multi-step peer review process that will help you be prepared and review for a thorough knowledge of Surgery-Urologic. When it is time for the Surgery-Urologic board and certification exam, you will already be ready. Besides online study quizzes, we also publish our peer-reviewed content in eBooks and mobile Apps. We also offer inexpensive CME/CE, so our content can be used to attain education credits while you study Surgery-Urologic.